← Back to patent-cliff list
CAS 1218-69-5
2-(2-hydroxyphenyl)-4H-benzo[e][1,3]oxazin-4-one
Codes: DEFE-003
Application context (from source-drug indications)
ThalassaemiaDeferasiroxIron overloadDeferasiroxBeta thalassaemiaDeferasiroxHaematopoietic stem cell transplantationDeferasiroxMyelodysplastic syndromeDeferasiroxAnaemiaDeferasirox
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Deferasirox | Tier B — Position early | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
2-hydroxybenzoyl chloride→2-hydroxybenzamide→2-(2-hydroxyphenyl)-4H-benzo[e][1,3]oxazin-4-one→4-hydrazinylbenzoic acid
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.